Evidence map›Paper›PMID 27803178›Full record

ArticleOccupational and environmental medicine2017

Occupational exposure to chlorinated solvents and kidney cancer: a case-control study.

Mark P Purdue, Patricia A Stewart, Melissa C Friesen, Joanne S Colt, Sarah J Locke, Misty J Hein, Martha A Waters, Barry I Graubard, Faith Davis, Julie Ruterbusch and 4 more

Open access · greenAbstract read
In one paragraph

Article in Occupational and environmental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Extended Mortality Follow-up of a Cohort of Dry Cleaners.Epidemiology (Cambridge, Mass.) · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Mark P PurdueDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Patricia A StewartStewart Exposure Assessments, LLC, Arlington, USA.
Melissa C FriesenDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Joanne S ColtDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Sarah J LockeDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-4827-222X
Misty J HeinCACI, Inc., Cincinnati, Ohio, USA.
Martha A WatersDivision of Applied Research and Technology, National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA.
Barry I GraubardDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Faith DavisUniversity of Alberta, Edmonton, Alberta, Canada.
Julie RuterbuschDepartment of Family Medicine and Public Health Sciences, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
Kendra SchwartzDepartment of Family Medicine and Public Health Sciences, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
Wong-Ho ChowDepartment of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Jonathan N HofmannDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
National Institutes of Health · USWayne State University · USCACI International (United States) · USNational Institute for Occupational Safety and Health · USThe University of Texas MD Anderson Cancer Center · USUniversity of Alberta · CA

Funding

Cancer Risk in Human PopulationsZIACP010136 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI PURDUE, MARK · 2009 to 2025
$36.7M
CANCER RISK IN HUMAN POPULATIONSZ01CP010136 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SILVERMAN, DEBRA · 1997 to 2008
$5.1M
Intramural NIH HHS Z01 CP010136
6 · The paper itself

Abstract

objectivesTrichloroethylene, a chlorinated solvent widely used for metal degreasing, is classified by the International Agency for Research on Cancer as a kidney carcinogen. Other chlorinated solvents are suspected carcinogens, most notably the cleaning solvent perchloroethylene, although it is unclear whether they are associated with kidney cancer. We investigated kidney cancer associations with occupational exposure to 6 chlorinated solvents (trichloroethylene, perchloroethylene, 1,1,1-trichloroethane, carbon tetrachloride, chloroform, and methylene chloride) within a case-control study using detailed exposure assessment methods.

methodsCases (n=1217) and controls (n=1235) provided information on their occupational histories and, for selected occupations, on tasks involving potential exposure to chlorinated solvents through job-specific interview modules. Using this information, an industrial hygienist assessed potential exposure to each solvent. We computed ORs and 95% CIs for different exposure metrics, with unexposed participants as the referent group.

results1,1,1-trichloroethane, carbon tetrachloride, chloroform, and methylene chloride were not associated with kidney cancer. Among jobs with high exposure intensity, high cumulative hours exposed to perchloroethylene was associated with increased risk, both overall (third tertile vs unexposed: OR 3.1, 95% CI 1.3 to 7.4) and after excluding participants with ≥50% exposure probability for trichloroethylene (OR 3.0, 95% CI 0.99 to 9.0). A non-significant association with high cumulative hours exposed to trichloroethylene was observed (OR 1.7, 95% CI 0.8 to 3.8).

conclusionsIn this study, high exposure to perchloroethylene was associated with kidney cancer, independent of trichloroethylene. Additional studies are needed to further investigate this finding.

Indexed as

AdultCase-Control StudiesFemaleHumansHydrocarbons, ChlorinatedInterviews as TopicKidney NeoplasmsLogistic ModelsMaleMichiganMiddle AgedOccupational DiseasesOccupational ExposureSolventsTetrachloroethyleneTrichloroethyleneHydrocarbons, ChlorinatedSolventsTetrachloroethyleneTrichloroethylenecase-control studieschlorinated solvents

Identifiers

PMID27803178
PMCPMC5761658
OpenAlexW2540112823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.